Investor insights
Sectors invested in
Funding rounds participated in
$55M sweet spot round size
Most of their 19 investments are in rounds between $26M and $75M
Basic info
Industry
Sectors
Date founded
2010
Investments made
Taysha Gene Therapies raised $150M on August 14, 2023
Investors: RTW Investments, LP, Octagon Capital Advisors, GordonMD Global Investments LP, RA Capital Management, L.P., TCG X, The Invus Group, B Capital Group and PBM Capital Group
LEXEO Therapeutics raised $100M on September 9, 2021
Investors: Laurion Capital Management LP, Gray's Creek Capital Partners, Lundbeckfonden / Lundbeck Foundation, Omega Funds, Longitude Capital, Intus Capital, Woodline Partners LP and PBM Capital Group
Xalud Therapeutics, Inc. raised $30M on August 24, 2021
Investors: PBM Capital Group
GenapSys raised $70M on May 27, 2021
Investors: Farallon Capital Management, Soleus Capital Management, L.P. and PBM Capital Group
SalioGen Therapeutics raised $20M on February 18, 2021
Investors: PBM Capital Group
PatientsLikeMe raised $26M on February 9, 2021
Investors: W.R. Hambrecht + Co., Optum Ventures, Alta Partners and PBM Capital Group
LEXEO Therapeutics raised $85M on January 7, 2021
Investors: Lundbeckfonden / Lundbeck Foundation, Omega Funds, Woodline Partners LP, The Invus Group, Longitude Capital and PBM Capital Group
Acumen Pharmaceuticals, Inc. raised $75M on November 20, 2020
Investors: RA Capital Management, L.P., Sands Capital Management and PBM Capital Group
Taysha Gene Therapies raised $95M on August 5, 2020
Investors: Nolan Capital, Inc., GV, Perceptive Advisors, Sands Capital Management, Octagon Capital, The Invus Group and PBM Capital Group
Verona Pharma raised $200M on July 17, 2020
Investors: Perceptive Advisors, Samsara BioCapital, RA Capital Management, L.P., Soleus Capital Management, L.P., Novo Holdings, OrbiMed Advisors, Vivo Capital, Polar Capital Partners and PBM Capital Group